
Overview
Tomasz Ryszard is a Nephrologist in Durham, North Carolina. Dr. Ryszard has been practicing medicine for over 32 years and is rated as an Experienced provider by MediFind in the treatment of Pseudohypoaldosteronism Type 2. His top areas of expertise are End-Stage Renal Disease (ESRD), Chronic Kidney Disease, Acute Kidney Failure, and Nephrosclerosis.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
Accepted plan types not found. Please verify directly with the provider.
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
3643 N Roxboro St, Durham, NC 27704
University Of North Carolina At Chapel Hill
Gerald Hladik is a Nephrologist in Chapel Hill, North Carolina. Dr. Hladik is rated as an Advanced provider by MediFind in the treatment of Pseudohypoaldosteronism Type 2. His top areas of expertise are Pseudohypoaldosteronism Type 2, Liddle Syndrome, Chronic Kidney Disease, and Glomerulonephritis. Dr. Hladik is currently accepting new patients.
James Godwin is a Nephrologist in Cary, North Carolina. Dr. Godwin is rated as a Distinguished provider by MediFind in the treatment of Pseudohypoaldosteronism Type 2. His top areas of expertise are End-Stage Renal Disease (ESRD), Chronic Kidney Disease, Nephrosclerosis, and Renovascular Hypertension. Dr. Godwin is currently accepting new patients.
Boice-Willis Clinic PA
Saritha Boyapati is a Nephrologist in Rocky Mount, North Carolina. Dr. Boyapati is rated as an Advanced provider by MediFind in the treatment of Pseudohypoaldosteronism Type 2. Her top areas of expertise are Acute Kidney Failure, Chronic Kidney Disease, End-Stage Renal Disease (ESRD), and Necrosis. Dr. Boyapati is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Acute Kidney FailureDr. Ryszard isDistinguished. Learn about Acute Kidney Failure.
- Chronic Kidney DiseaseDr. Ryszard isDistinguished. Learn about Chronic Kidney Disease.
- End-Stage Renal Disease (ESRD)Dr. Ryszard isDistinguished. Learn about End-Stage Renal Disease (ESRD).
- NephrosclerosisDr. Ryszard isDistinguished. Learn about Nephrosclerosis.
- Advanced
- Acute Tubular NecrosisDr. Ryszard isAdvanced. Learn about Acute Tubular Necrosis.
- Diabetic NephropathyDr. Ryszard isAdvanced. Learn about Diabetic Nephropathy.
- NecrosisDr. Ryszard isAdvanced. Learn about Necrosis.
- Nephrogenic Diabetes InsipidusDr. Ryszard isAdvanced. Learn about Nephrogenic Diabetes Insipidus.
- Renovascular HypertensionDr. Ryszard isAdvanced. Learn about Renovascular Hypertension.
- Thin Basement Membrane NephropathyDr. Ryszard isAdvanced. Learn about Thin Basement Membrane Nephropathy.
- Experienced
- Analgesic NephropathyDr. Ryszard isExperienced. Learn about Analgesic Nephropathy.
- Autosomal Dominant HypocalcemiaDr. Ryszard isExperienced. Learn about Autosomal Dominant Hypocalcemia.
- Autosomal Dominant Polycystic Kidney Disease
- Childhood Hypophosphatasia (HPP)Dr. Ryszard isExperienced. Learn about Childhood Hypophosphatasia (HPP).
- Congenital Nephrotic SyndromeDr. Ryszard isExperienced. Learn about Congenital Nephrotic Syndrome.
- Familial Hypocalciuric Hypercalcemia Type 1
